Overview

Sulodexide Efficacy in Chronic Idiopathic Subjective Tinnitus

Status:
Completed
Trial end date:
2017-08-01
Target enrollment:
Participant gender:
Summary
The objective of this prospective randomized and double blind controlled study is to evaluate the efficacy and safety of Sulodexide (25 mg) in the treatment of chronic idiopathic subjective tinnitus.
Phase:
Phase 2
Details
Lead Sponsor:
St Joseph University, Beirut, Lebanon
Treatments:
Glucuronyl glucosamine glycan sulfate